antipsychotics

3 Biotechs With Upcoming Product Launches

3 Biotechs With Upcoming Product Launches

Seeking Alpha

Alexza Is Meaningfully Overvalued Following Its Latest Rally

Alexza Is Meaningfully Overvalued Following Its Latest Rally

Seeking Alpha

Forest Labs submits potential antipsychotic treatment cariprazine for FDA review

Forest Labs submits potential antipsychotic treatment cariprazine for FDA review

Yahoo/AP

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

TheStreet.com

Acadia's Bubbling To Move Higher

Acadia's Bubbling To Move Higher

Seeking Alpha

J&J Pushed Risperdal With Golf, Popcorn, Witness Says

J&J Pushed Risperdal With Golf, Popcorn, Witness Says

Bloomberg

J&J Settles Risperdal Lawsuit on Opening Day of Trial

J&J Settles Risperdal Lawsuit on Opening Day of Trial

Bloomberg

Eli Lilly treatment for acute schizophrenia fails in late-stage study comparing it to placebo

Eli Lilly treatment for acute schizophrenia fails in late-stage study comparing it to placebo

Yahoo/AP

J&J Said To Pay $2.2 Billion To End Risperdal Sales Probe

J&J Said To Pay $2.2 Billion To End Risperdal Sales Probe

Bloomberg

Will the FDA Approve Alexza's Adasuve?

Will the FDA Approve Alexza's Adasuve?

Motley Fool